Kyntra Bio Inc.
KYNB | NASDAQ
$4.57
-$0.08 (-1.72%)
At close: Oct 30, 2026, 4:00 PM ET
$4.69
+$0.12 (+2.63%)
After-hours:
Oct 30, 2026, 5:07 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | 6.44M | 29.62M | 46.8M | 140.73M | 235.31M | 176.32M |
Cost of Revenue | 556K | 15.56M | 3.96M | 20.28M | 449.19M | 8.87M |
Gross Profit | 5.88M | 14.06M | 42.84M | 120.45M | -213.88M | 167.45M |
Operating Income | -45.9M | -150.42M | -322.72M | -301.03M | -288.53M | -191.88M |
Interest Income | 2.94M | 5.3M | 7.59M | 7.6M | n/a | 5.55M |
Pretax Income | -58.29M | -153.37M | -323.22M | -293.3M | -289.68M | -188.93M |
Net Income | 183.45M | -47.58M | -284.23M | -293.65M | -290.02M | -189.29M |
Selling & General & Admin | 27.71M | 49.33M | 86.48M | 124.69M | n/a | 106.41M |
Research & Development | 23.52M | 95.69M | 266.47M | 296.79M | 387.04M | 252.92M |
Other Expenses | 553K | 19.45M | 12.61M | n/a | -312.4M | n/a |
Operating Expenses | 51.78M | 164.48M | 365.56M | 421.48M | 74.65M | 359.33M |
Interest Expense | 8.76M | 8.25M | 8.1M | 1.44M | 1.08M | 2.4M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 52.34M | 180.04M | 369.52M | 441.76M | 523.84M | 368.2M |
Income Tax Expense | -90K | -269K | -252K | 358K | 347K | 360K |
Shares Outstanding (Basic) | 4.04M | 4M | 3.89M | 3.74M | 3.69M | 3.59M |
Shares Outstanding (Diluted) | 4.04M | 4M | 3.89M | 3.74M | 3.69M | 3.59M |
EPS (Basic) | 45.37 | -0.48 | -2.92 | -3.15 | -3.15 | -2.11 |
EPS (Diluted) | 45.37 | -0.48 | -2.92 | -3.15 | -3.15 | -2.11 |
EBITDA | -57.55M | -142.43M | -305.2M | -282.83M | -333.72M | -164.28M |
EBIT | -58.29M | -145.12M | -315.13M | -293.43M | -348.53M | -186.33M |
Depreciation & Amortization | 748K | 2.69M | 9.93M | 10.6M | 14.81M | 22.05M |
Add to Watchlist
Select watchlists to add or remove KYNB